In 2024, Gene Investments SIA had revenue of 2.7 million EUR and profit of 1.7 million EUR. The company has 2 employees. Beneficial owners: Alens Baibekovs, Ēriks Baibekovs.
| year | 2024Latest | 2023 | 2022 |
|---|---|---|---|
Revenue | 2,7m € +2.0% | 2,6m € +11.8% | 2,4m € +6.6% |
Profit | 1,7m € +5.3% | 1,6m € +4.1% | 1,6m € -53.8% |
Assets | 12,4m € -2.6% | 12,7m € +0.0% | 12,7m € -1.7% |
Liabilities | 6m € +15.4% | 5,2m € -17.7% | 6,3m € -14.6% |
Equity | 6,4m € -15.1% | 7,5m € +17.7% | 6,4m € +15.7% |
Employees | 2 +100.0% | 1 +0.0% | 1 +0.0% |
Overall rating | A+97/100 |
Financial health | 100/100 |
Credit history | 100/100 |
Legal history | 100/100 |
Business activity | 85/100 |
| Overall risk | Low |
No risk flags | |
No tax debts | |
Positive profit | |
Regular report filing | |
| Name, surname | Birth date | Position | Representation rights | Registered | |
|---|---|---|---|---|---|
| Board member | Independently | ||||
| Board member | Independently | ||||
| Board member | Independently |
| Name | Changed |
|---|---|
| "Geneba LV Investments" KS | 31 March 2017 |
| "Homburg LV Investments" KS | 10 December 2013 |
| "Geneba LV Investments" KS | 31 March 2017 |
| "Homburg LV Investments" KS | 10 December 2013 |
| "Geneba LV Investments" KS | 31 March 2017 |
| "Homburg LV Investments" KS | 10 December 2013 |
| "Geneba LV Investments" KS | 31 March 2017 |
| "Homburg LV Investments" KS | 10 December 2013 |
| "Geneba LV Investments" KS | 31 March 2017 |
| "Homburg LV Investments" KS | 10 December 2013 |
| "Geneba LV Investments" KS | 31 March 2017 |
| "Homburg LV Investments" KS | 10 December 2013 |
| "Geneba LV Investments" KS | 31 March 2017 |
| "Homburg LV Investments" KS | 10 December 2013 |
| "Geneba LV Investments" KS | 31 March 2017 |
| "Homburg LV Investments" KS | 10 December 2013 |
| "Geneba LV Investments" KS | 31 March 2017 |
| "Homburg LV Investments" KS | 10 December 2013 |
| "Geneba LV Investments" KS | 31 March 2017 |
| "Homburg LV Investments" KS | 10 December 2013 |
Gene Investments SIA is located at Ķekavas nov., Ķekavas pag., Valdlauči, Meistaru iela 1, LV-1076.
In 2024, Gene Investments SIA had revenue of 2 701 594 EUR and profit of 1 714 608 EUR. Compared to previous year, revenue increased by 2.0%. View full financial report →
In 2024, Gene Investments SIA had an average of 2 employees. View tax history →
The beneficial owners of Gene Investments SIA are Alens Baibekovs and Ēriks Baibekovs. View ownership details →
Yes, Gene Investments SIA is registered as an active VAT payer with VAT number LV40003977627.
In 2024, the average gross salary at Gene Investments SIA was approximately 510,90 € per month (net ~ 457,26 €). This is an approximate calculation. View salary details →
Gene Investments SIA was founded on December 12, 2007. The company has been operating for 19 years.
| Indicator | Value | Rank | Comparison | |
|---|---|---|---|---|
Company age | 19 years | 73 - 77 | 81% | |
Net revenue | 2 701 594,00 € | 7 - 11 | 98% | |
Profit | 1 714 608,00 € | 1 - 4 | 100% | |
Equity | 6 380 626,00 € | 1 - 4 | 100% | |
Assets | 12 408 746,00 € | 1 - 4 | 100% | |
Fixed assets | 12 080 000,00 € | - | 90% | |
Liquidity | 0.39 | - | 10% | |
Profitability | 63.5% | - | 90% | |
Registered capital | 2800,00 € | - | 60% |
Annual financial report for 2024.
Annual financial report for 2023.
Annual financial report for 2022.
Annual financial report for 2021.
Annual financial report for 2020.
Annual financial report for 2019.
Registered in the Latvian company register.
| Name, surname | Shares | Ownership rights | |
|---|---|---|---|
| Sabiedrība ar ierobežotu atbildību "CHEMISPEC" | 1400 | 50.00% | |
| SIA "BOOKING GROUP" | 1400 | 50.00% |
| Name, surname | Nationality | Birth date | |
|---|---|---|---|
| Alens Baibekovs | LV | ||
| Ēriks Baibekovs | LV |